REPSA: combinatorial approach for identifying preferred drug-DNA binding sequences.

Keywords

DNA, Small molecule, DNA binding site, Computational biology, Netropsin

References

• Molecular Aspects of Anticancer Drug/DNA InteractionsStephen Neidle, Michael J. Waring — 1993
• Fitting a Mixture Model By Expectation Maximization To Discover Motifs In BiopolymerTrisha L. Bailey, Charles Elkan — 1994
• Identification of preferred hTBP DNA binding sites by the combinatorial method REPSA.Paul Hardenbol — 1997
• Identification of preferred actinomycin-DNA binding sites by the combinatorial method REPSA.Jianjun Shen — 2001
• Exploring molecular diversity with combinatorial shape libraries.Daniel J. Kenan, Donald E. Tsai, J. D. Keene — 1994
• CASTing for multicomponent DNA-binding complexes.Woodring E. Wright, Walter D. Funk — 1993
• In vitro genetics.Jack W. Szostak — 1992
• Molecular recognition of DNA by small molecules.Peter B. Dervan — 2001
• Class-IIS restriction enzymes--a review.Waclaw Szybalski, Sun C. Kim, Noaman Hasan — 1991
• Sequence specificity of triplex DNA formation: Analysis by a combinatorial approach, restriction endonuclease protection selection and amplification.Paul Hardenbol, Michael W. Van Dyke — 1996
• Identification of preferred distamycin-DNA binding sites by the combinatorial method REPSA.Paul Hardenbol, Jo C. Wang, Michael W. Van Dyke — 1997
• Combinatorial identification of a novel consensus sequence for the covalent DNA-binding polyamide tallimustine.Gulshan Sunavala‐Dossabhoy, Michael W. Van Dyke — 2005
• Diversity of oligonucleotide functions.Larry Gold, Barry Polisky, Olke C. Uhlenbeck — 1995
• In vitro selection of functional nucleic acids.David Sloan Wilson, Jack W. Szostak — 1999
• Proceedings: Second international conference on intelligent systems for molecular biologyRobert A. Altman, Douglas L. Brutlag, Peter D. Karp — 1994

Cited by

• Anti- Japanese-Encephalitis-Viral Effects of Kaempferol and Daidzin and Their RNA-Binding CharacteristicsTing Zhang, Zhìqiáng Wú, Jiang Du — 2012
• Recent advances in predicting protein classification and their applications to drug development.Xuan Xiao, Wei‐Zhong Lin, Kuo‐Chen Chou — 2013
• Drug target identification in protozoan parasitesJoachim Müller, Andrew Hemphill — 2016
• Using Restriction Endonuclease, Protection, Selection, and Amplification to Identify Preferred DNA-Binding Sequences of Microbial Transcription FactorsJohn K. Barrows, Michael W. Van Dyke — 2023

Related papers

• Interaction of p53 with its consensus DNA-binding siteYun Wang, J F Schwedes, Dorothy Parks — 1995
• Binding of Nucleoid-Associated Protein Fis to DNA Is Regulated by DNA Breathing DynamicsKristy Nowak‐Lovato, Ludmil B. Alexandrov, Afsheen Banisadr — 2013
• Binding of transcription factor GabR to DNA requires recognition of DNA shape at a location distinct from its cognate binding siteWalid Al-Zyoud, Robert MG. Hynson, L.A. Ganuelas — 2015
• Pax-3-DNA interaction: flexibility in the DNA binding and induction of DNA conformational changes by paired domains.Georges Chalepakis, Jan Wijnholds, Peter Gruss — 1994
• Covariation between homeodomain transcription factors and the shape of their DNA binding sitesIris Dror, Tianyin Zhou, Yael Mandel‐Gutfreund — 2013
• MPE•Fe(II) Footprinting: Drug Binding Sites on Native DNAW Michael — 1984
• Design of Sequence‐specific DNA Cleaving MoleculesPeter B. Dervan, Brenda F. Baker — 1986
• Structural predictions of protein–DNA binding: MELD-DNAReza Esmaeeli, Antonio Bauzá, Alberto Pérez — 2023
• DNAgenie: accurate prediction of DNA-type-specific binding residues in protein sequencesJian Zhang, Sina Ghadermarzi, Akila Katuwawala — 2021